AfroCAB issued a statement from community and civil society leaders, advocates and activists meeting on long-acting drugs for the prevention and treatment of HIV which took place in Nairobi in April 2023.
In this statement, the community demands rapid action from Gilead to make lenacapavir accessible in low- and middle-income countries without further delay!
See the statement below:
Source : AfroCAB
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.